Skip to main content
OpenTrials
Completed

NCT Number: NCT04841330

Prospective Healthy Volunteer Study of the Securis™ Stabilization Device

This study is being conducted to assess the performance of the Securis™ Stabilization Device in simulated clinical use.

Completed

Looking for future studies?

Notify Me

Key information

Age range

14 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

TKL Research, Inc

Fair Lawn, New Jersey, 07410, United States

About this study

This study is designed to collect prospective observational data related to the safety and performance of the Securis™ Stabilization Device in healthy volunteers utilizing a simulated use method. Participants will have an intravenous catheter applied (not inserted) onto their forearm with a Securis™ Stabilization Device applied over it. The site/device will be assessed over a period of 9 days (ideally Days 0-7 in-clinic and Day 8 virtually). The assessments will include the appearance of the site, the appearance of the dressing, and the movement of the catheter tip under the dressing.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ≥14 years of age, regardless of gender, at the time of informed consent
  • Is expected to be available through Day 8 of the study
  • Is expected to understand and follow the study procedures including applicable restrictions in activities (e.g., limited physical exercise, no swimming, no use of lotions/moisturizers, etc.)
  • Provision of signed and dated informed consent form. Note: Consent of a parent of legal guardian will be require for participants <18 years of age; assent will also be required for these participants

Exclusion criteria

  • Significant scarring at the device application site
  • Has any skin condition that might affect device adherence or the ability of study staff to perform skin assessments
  • Has any condition or is taking any medication that might cause excessive bruising, bleeding, or skin tearing (e.g., anti-coagulant therapy)
  • Known allergy to study device/components or ancillary devices
  • Will be unable to complete a remote visit via video chat, if required
  • Has any condition which, in the opinion of the Investigator, precludes them from participation in this study.

Treatment and study plan

Securis™ Stabilization Device

Device

A trained clinician will apply and remove, and participants will wear the Securis™ Stabilization Device for up to one week (7 days) on their forearm. A shortened catheter will be placed (not inserted) over the Securis™ device in accordance with the product Information for Use (IFU), and an extension set attached to the catheter and secured in place, to simulate clinical use.

Primary outcomes

  1. Rate of Securis™ Stabilization Device Securement Failure During Simulated Use

    Time frame: From time of placement and up to 8 days after removal

    Device securement failure is defined as any of the following:

    • Loose dressing
    • Soiled under dressing
    • Complete failure (complete removal)
    • Dislodgement of device or catheter
  2. Percentage of Participants with Select Skin Conditions Observed During Securis™ Stabilization Device Use

    Time frame: From placement and up tp to 24 hours after device removal

    Select skin conditions include any of the following:

    • Blister
    • Rash
    • Skin tear
    • Bruising
    • Exudate

Secondary outcomes

  1. Rate of Securis™ Stabilization Device-related Adverse Events

    Time frame: From placement and up to 24 hours after device removal

    Rate of device-related adverse events calculated as the number of participants with adverse events related to the device divided by the total number of evaluable participants.

Sponsors and collaborators

Lead sponsor

Becton, Dickinson and Company

Industry

Registry information

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Apr 12, 2021
Registry last updated
Sep 8, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.